PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析

◆英語タイトル:PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15859
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PQ Group Holdings Inc (PQG) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PQ Group Holdings Inc (PQ Group) is a manufacturer of catalysts, specialty materials, and chemicals. It offers silica catalysts, zeolite catalysts, refining services, silicate products and its derivatives, and specialty glass products. The company’s products and services caters to fuels and emissions controls, consumer products, packaging and engineering plastics, highway safety and construction, industrial and process chemicals, and natural resources markets. PQ Group’s refining services include recycling and logistics for refiners that use sulfuric acid in their alkylation units. The company conducts business operations across Asia-Pacific, North America, South America, and Europe. PQ Group is headquartered in Malvern, Pennsylvania, the US.

PQ Group Holdings Inc Key Recent Developments

Feb 21,2019 PQ Group Holdings reports fourth quarter and full year 2018 results
Nov 06,2018 PQ Group Holdings reports third quarter 2018; updates 2018 guidance raising adjusted free cash flow outlook to $125 million to $140 million, a yield of ~ 6%
Sep 26,2018 PQ Initiates pay down of term loan
May 10,2018 PQ Group Holdings Reports Solid First Quarter 2018, Reaffirms 2018 Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
PQ Group Holdings Inc – Key Facts
PQ Group Holdings Inc – Key Employees
PQ Group Holdings Inc – Key Employee Biographies
PQ Group Holdings Inc – Major Products and Services
PQ Group Holdings Inc – History
PQ Group Holdings Inc – Company Statement
PQ Group Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
PQ Group Holdings Inc – Business Description
Business Segment: Environmental Catalysts and Services
Overview
Performance
Business Segment: Performance Materials and Chemicals
Overview
Performance
Geographical Segment: Netherlands
Performance
Geographical Segment: Other foreign countries
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States
Performance
R&D Overview
PQ Group Holdings Inc – Corporate Strategy
PQ Group Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
PQ Group Holdings Inc – Strengths
PQ Group Holdings Inc – Weaknesses
PQ Group Holdings Inc – Opportunities
PQ Group Holdings Inc – Threats
PQ Group Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 21, 2019: PQ Group Holdings reports fourth quarter and full year 2018 results
Nov 06, 2018: PQ Group Holdings reports third quarter 2018; updates 2018 guidance raising adjusted free cash flow outlook to $125 million to $140 million, a yield of ~ 6%
Sep 26, 2018: PQ Initiates pay down of term loan
May 10, 2018: PQ Group Holdings Reports Solid First Quarter 2018, Reaffirms 2018 Guidance
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
PQ Group Holdings Inc, Key Facts
PQ Group Holdings Inc, Key Employees
PQ Group Holdings Inc, Key Employee Biographies
PQ Group Holdings Inc, Major Products and Services
PQ Group Holdings Inc, History
PQ Group Holdings Inc, Other Locations
PQ Group Holdings Inc, Subsidiaries
PQ Group Holdings Inc, Key Competitors
PQ Group Holdings Inc, Ratios based on current share price
PQ Group Holdings Inc, Annual Ratios
PQ Group Holdings Inc, Annual Ratios (Cont...1)
PQ Group Holdings Inc, Annual Ratios (Cont...2)
PQ Group Holdings Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
PQ Group Holdings Inc, Performance Chart (2014 - 2018)
PQ Group Holdings Inc, Ratio Charts

★海外企業調査レポート[PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Puccino’s Worldwide Ltd:企業の戦略・SWOT・財務情報
    Puccino's Worldwide Ltd - Strategy, SWOT and Corporate Finance Report Summary Puccino's Worldwide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sears Canada, Inc.:企業の戦略・SWOT・財務分析
    SummarySears Canada, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Semma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Semma Therapeutics Inc (Semma Therapeutics) is a biotechnology company that develops cell replacement therapy for the treatment of diabetes. The company develops therapies using stem cells of the individuals with Type 1 diabetes to produce their own insulin that will regulate the blood sugar …
  • Apache Corporation:企業の戦略・SWOT・財務情報
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Entellus Medical Inc (ENTL):企業財務及び戦略的SWOT分析
    Summary Entellus Medical Inc (Entellus Medical) is a medical device company that offers invasive products for the treatment of patients afflicted by chronic sinusitis. The company offers XprESS, navigation, post operative care products and surgical instruments. Its XprESS products is used by ear, no …
  • Suzuken Co., Ltd. (9987)(製薬・医療分野):企業M&A動向
    Summary Suzuken Co., Ltd. (SUZUKEN) is a pharmaceutical company. The company provides ethical pharmaceuticals, diagnostic regents, medical equipment and supplies, and medical foods. It develops and manufactures medical equipment. Suzuken also offers home nursing care services, clinical testing servi …
  • Renown Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Renown Incorporated Mergers and …
  • Polski Koncern Miesny DUDA S.A.:企業の戦略・SWOT・財務分析
    Polski Koncern Miesny DUDA S.A. - Strategy, SWOT and Corporate Finance Report Summary Polski Koncern Miesny DUDA S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Myers Industries, Inc. (MYE):企業財務及び戦略的SWOT分析
    Summary Myers Industries, Inc. (Myers) is a chemical company that manufactures polymer products for material handling. The company also distributes tools, equipment and supplies to tire, wheel and undervehicle service industry. Its products include plastic storage and organization containers, custom …
  • Liuzhou Chemical Industry Co., Ltd. (600423):企業概要、財務及び戦略的SWOT分析
    Summary Liuzhou Chemical Industry Co., Ltd. (Liuzhou Chemical) is a chemical manufacturing company. The company is into production and sale of fertilizers and chemical products. Its products include ammonia, urea, ammonium nitrate, soda ash, ammonium chloride, sodium nitrate, sodium nitrite, ammoniu …
  • Silicon Laboratories, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Silicon Laboratories, Inc. Merg …
  • CNS Response, Inc. (CNSO):企業の財務及び戦略的SWOT分析
    Summary CNS Response, Inc. (CNS) is a healthcare company that offers technology solutions. The company conducts analysis and research, and develops and markets patented platform technology that allows psychiatrists and other physicians to determine a proper treatment for patients with behavioral dis …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Albany Molecular Research, Inc. (AMRI):企業の財務及び戦略的SWOT分析
    Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Celltrion, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Celltrion, Inc. Mergers and Acq …
  • Knight Therapeutics Inc (GUD):製薬・医療:M&Aディール及び事業提携情報
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used in the treatment of metabolic diseases, derma …
  • Lumosa Therapeutics Co Ltd (6535):製薬・医療:M&Aディール及び事業提携情報
    Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) is a developer of drugs for the treatment of neurological and inflammatory diseases. The company’s pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3001, a novel small molecule for acute ischemic stroke. …
  • L. Possehl and Co. mbH:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' L. Possehl and Co. mbH Mergers …
  • Semperit AG Holding (SEM):企業の財務及び戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a medical device company that develops, produces and sells specialized rubber and plastic products. The company’s products include surgical gloves, examination gloves, disposable protective gloves and reusable protective gloves. It also offers hydraulic hose …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆